New model of irregular heartbeat could boost drug efficacy
Jonathan Silva, a biomedical engineer in the McKelvey School of Engineering at Washington University in St. Louis, has developed the first computational model that shows the molecular groundwork of a popular drug’s effectiveness in a variety of ways.
Edging closer to personalized medicine for patients with irregular heartbeat
An international team, including faculty from the School of Engineering & Applied Science at Washington University in St. Louis, has used genetic phenotype to determine which patients would benefit the most from a commonly used drug treatment.